Based on the Data from the Zhejiang Emergency Center, Explore the Independent and Interactive Effects of the Association Between Meteorological Factors and Air Pollution and the Number of Emergency Personnel, Identify the Relevant Vulnerable Population Characteristics, Sensitive Disease Types
Launched by LI HENGJIE · Jan 23, 2025
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -Emergency data of Zhejiang Emergency Command Center in the past 5 years
- Exclusion Criteria:
- • Prehospital emergency information from non-Zhejiang province domains
- • Emergency calls due to labor and delivery.
About Li Hengjie
Li Hengjie is a distinguished clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing cutting-edge therapies, Li Hengjie collaborates with leading research institutions and healthcare professionals to conduct rigorous clinical studies. The organization prioritizes patient safety and ethical standards, ensuring that all trials adhere to regulatory guidelines while striving to generate impactful data that can enhance treatment options across various medical fields. Through its dedication to scientific excellence and collaboration, Li Hengjie aims to contribute significantly to the advancement of healthcare and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported